Award to bolster the development of a new liver disease test
18 December, 2018 
Pictured: Dr Hui Emma Zhang, Professor Mark Gorrell and Dr Avik Majumdar
Collaborative research between the Centenary Institute and Royal Prince Alfred Hospital has been recognised with a prestigious award.
Dr Avik Majumdar, a staff specialist transplant hepatologist at RPA Hospital, is among six recipients of the 2019 Gilead Australia Fellowship Program, which awarded a total of $250,000 for these six research projects.
Dr Majumdar has been collaborating with several Centenary researchers on the project, including Head of the Liver Enzymes in Metabolism and Inflammation Program Professor Mark Gorrell, Head of the Liver injury and Cancer Program Professor Geoff McCaughan, and Dr Hui Emma Zhang.
The group is working to validate an alternative test for people with non-alcoholic fatty liver disease (NAFLD), to understand whether a patient is at risk of developing more severe disease, and requires further treatment.
Congratulations Dr Majumdar and your collaborators at Centenary on this significant achievement!
Learn more about Centenary’s Liver Enzymes in Metabolism and Inflammation and Liver Injury and Cancer Programs.
Read about how Dr Hui Emma Zhang led a recent study, which discovered dozens of new likely targets for particular enzyme (FAP) that is within most tumours.
